Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(3):352–363. doi: 10.1111/j.1750-3639.2003.tb00034.x

Pathological Adhesion of Primary Human Schwannoma Cells is Dependent on Altered Expression of Integrins

Tamara Utermark 1, Katherine Kaempchen 1, C Oliver Hanemann 1,✉
PMCID: PMC8095832  PMID: 12946024

Abstract

Mutations in the tumor suppressor gene coding for merlin cause Neurofibromatosis type 2 (NF2), all spontaneous schwannomas, and a majority of meningiomas. Merlin links transmembrane proteins to the cytoskeleton. Accordingly, primary human schwannoma cells lacking merlin show an increased number of lamellipodia and filopodia as well as increased cell spreading. We show enhanced adhesion in primary human schwannoma cells and present evidence that this is dependent on the integrin chains α6β1 and α6β4. We further demonstrate that the integrin chains β1 and β4 are upregulated in schwannomas using different complementary methods, and report higher expression of these integrins per schwannoma cell by fluorescence assisted cell sorting (FACS). Finally we report clustering of the integrin chains α6, β1, and β4 on schwannoma cells. Our findings fit well into recent data on the role of merlin in signaling cascades connected to integrins and help explain pathological ensheathment of extracellular matrix or pseudomesaxon formation which is a hallmark of schwannoma histopathology.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

References

  • 1. . (1994) National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma , December 1113, 1991. The Consensus Development Panel. Arch Neurol 51:201–207. [DOI] [PubMed] [Google Scholar]
  • 2. Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N (2002) The Neurofibromatosis Type 2 Gene Product, merlin, Reverses the F‐Actin Cytoskeletal Defects in Primary Human Schwannoma Cells. Mol Cell Biol 22:1150–1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Bijisma EK, Brouwer‐Mladin R, Bosch DA, Sterveld A, Hulsebos TJM (1992) Molecular characterization of chromosome 22 deletions in schwannomas. Genes Chromosomes Cancer 5:201–205. [DOI] [PubMed] [Google Scholar]
  • 4. Chomczynski P, Sacchi N (1987) Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 162:156–159. [DOI] [PubMed] [Google Scholar]
  • 5. Clark EA, Hynes RO (1996) Ras activation is necessary for integrin‐mediated activation of extracellular signal‐regulated kinase 2 and cytosolic phospholipase A2 but not for cytoskeletal organization. J Biol Chem 271:14814–14818. [DOI] [PubMed] [Google Scholar]
  • 6. Coppolino MG, Dedhar S (2000) Bi‐directional signal transduction by integrin receptors. Int J Biochem Cell Biol 32:171–188. [DOI] [PubMed] [Google Scholar]
  • 7. D'Souza‐Schorey C, Boettner B, Van Aelst L (1998) Rac regulates integrin‐mediated spreading and increased adhesion of T lymphocytes. Mol Cell Biol 18:3936–3946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Deguen B, Merel P, Goutebroze L, Giovannini M, Reggio H, Arpin M, Thomas G (1998) Impaired interaction of naturally occurring mutant NF2 protein with actin‐based cytoskeleton and membrane. Hum Mol Gen 7:217–226. [DOI] [PubMed] [Google Scholar]
  • 9. del Pozo MA, Vicente‐Manzanares M, Tejedor R, Serrador JM, Sanchez‐Madrid F (1999) Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. European J Immunol 29:3609–3620. [DOI] [PubMed] [Google Scholar]
  • 10. Dickersin GR (1987) The electron microscopic spectrum of nerve sheath tumors. Ultrastruct Pathol 11:103–146. [DOI] [PubMed] [Google Scholar]
  • 11. Einheber S, Milner TA, Giancotti F, Salzer JL (1993) Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol 123:1223–1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Erlandson RA, Woodruff JM (1982) Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 49:273–287. [DOI] [PubMed] [Google Scholar]
  • 13. Evans JJ, Jeun SS, Lee JH, Harwalkar JA, Shoshan Y, Cowell JK, Golubic M (2001) Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas. J Neurosurg 94:111–117. [DOI] [PubMed] [Google Scholar]
  • 14. Feltri ML, Graus, Porta D, Previtali, S. C , Nodari, A , Migliavacca, B , Cassetti, A , Littlewood‐Evans, A , Reichardt, L. F , Messing, A , Quattrini, A , Mueller, U , and Wrabetz, L. (2002) Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 156:199–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Feltri ML, Scherer SS, Nemni R, Kamholz J, Vogelbacker H, Scott MO, Canal N, Quaranta V, Wrabetz L (1994) Beta 4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 120:1287–1301. [DOI] [PubMed] [Google Scholar]
  • 16. Frei R, Dowling J, Carenini S, Fuchs E, Martini R (1999) Myelin formation by Schwann cells in the absence of beta4 integrin. GLIA 27:269–274. [DOI] [PubMed] [Google Scholar]
  • 17. Giancotti FG, Stepp MA, Suzuki S, Engvall E, Ruoslahti E (1992) Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. J Cell Biol 118:951–959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Giovannini M, Robanus‐Maandag E, Niwa‐Kawakita M, van der V , Woodruff JM, Goutebroze L, Merel P, Berns A, Thomas G (1999) Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13:978–986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Gonzalez‐Agosti, C , Xu, L , Pinney, D , Beauchamp, R , Hobbs, W , Gusella, J , and Ramesh, V. (1996) The merlin tumor suppressor localizes preferentially in membrane ruffles. Oncogene 13:1239–1247. [PubMed] [Google Scholar]
  • 20. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357. [DOI] [PubMed] [Google Scholar]
  • 21. Gutmann DH, Giordano MJ, Fishback AS, Guha A (1997) Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 49:267–270. [DOI] [PubMed] [Google Scholar]
  • 22. Gutmann DH, Haipek CA, Hoang Lu K (1999) Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations. J Neurosci Res 58:706–716. [PubMed] [Google Scholar]
  • 23. Gutmann DH, Sherman L, Seftor L, Haipek C, Hoang Lu K, Hendrix M (1999) Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading. Hum Mol Gen 8:267–275. [DOI] [PubMed] [Google Scholar]
  • 24. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Mueller HW (1998) Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. GLIA 23:89–98. [DOI] [PubMed] [Google Scholar]
  • 25. Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER (1996) Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J Neurosurg 84:847–851. [DOI] [PubMed] [Google Scholar]
  • 26. Hsiao LL, Peltonen J, Jaakkola S, Gralnick H, Uitto J (1991) Plasticity of integrin expression by nerve‐derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro. J Clin Invest 87:811–820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Jaakkola S, Savunen O, Halme T, Uitto J, Peltonen J (1993) Basement membranes during development of human nerve: Schwann cells and perineurial cells display marked changes in their expression profiles for laminin subunits and beta 1 and beta 4 integrins. J Neurocytol 22:215–230. [DOI] [PubMed] [Google Scholar]
  • 28. Kawakami K, Tatsumi H, Sokabe M (2001) Dynamics of integrin clustering at focal contacts of endothelial cells studied by multimode imaging microscopy. J Cell Sci 114:3125–3135. [DOI] [PubMed] [Google Scholar]
  • 29. Kimura Y, Saya H, Nakao M (2000) Calpain‐dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.(In Process Citation). Neuropathology 20:153–160. [DOI] [PubMed] [Google Scholar]
  • 30. Languino LR, Ruoslahti E (1992) An alternative form of the integrin beta 1 subunit with a variant cytoplasmic domain. J Biol Chem 267:7116–7120. [PubMed] [Google Scholar]
  • 31. Lukashev ME, Werb Z (1998) ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8:437–441. [DOI] [PubMed] [Google Scholar]
  • 32. Mainiero F, Murgia C, Wary KK, Curatola AM, Pepe A, Blumemberg M, Westwick JK, Der CJ, Giancotti FG (1997) The coupling of alpha6beta4 integrin to Ras‐MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J 16:2365–2375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Merel P, Haong‐Xuan K, Sanson M, Moreau‐Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X (1995) Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Gene Chromosome Canc 13:211–216. [DOI] [PubMed] [Google Scholar]
  • 34. Milner R, Wilby M, Nishimura S, Boylen, K , Edwards G, Fawcett J, Streuli C, Pytela R, Ffrench‐Constant C (1997) Division of labor of Schwann cell integrins during migration on peripheral nerve extracellular matrix ligands. Dev Biol 185:215–228. [DOI] [PubMed] [Google Scholar]
  • 35. Niessen CM, Cremona O, Daams H, Ferraresi S, Sonnenberg A, Marchisio PC (1994) Expression of the integrin alpha 6 beta 4 in peripheral nerves: localization in Schwann and perineural cells and different variants of the beta 4 subunit. J Cell Sci 107:543–552. [DOI] [PubMed] [Google Scholar]
  • 36. Obremski VJ, Hall AM, Fernandez‐Valle C (1998) Merlin, the neurofibromatosis type 2 gene product, and beta1 integrin associate in isolated and differentiating Schwann cells. J Neurobiol 37:487–501. [PubMed] [Google Scholar]
  • 37. Pelton PD, Sherman LS, Rizvi TA, Marchionni MA, Wood P, Friedman RA, Ratner N (1998) Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells. Oncogene 17:2195–2209. [DOI] [PubMed] [Google Scholar]
  • 38. Previtali SC, Feltri ML, Archelos JJ, Quattrini A, Wrabetz L, Hartung H (2001) Role of integrins in the peripheral nervous system. Prog Neurobiol 64:35–49. [DOI] [PubMed] [Google Scholar]
  • 39. Roche PH, Figarella‐Branger D, Daniel L, Bianco N, Pellet W, Pellissier JF (1997) Expression of cell adhesion molecules in normal nerves, chronic axonal neuropathies and Schwann cell tumors. J Neurol Sci 151:127–133. [DOI] [PubMed] [Google Scholar]
  • 40. Rosenbaum C, Kluwe L, Mautner VF, Friedrich RE, Mueller HW, Hanemann CO (1998) Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients. Neurobiol Dis 5:55–64. [DOI] [PubMed] [Google Scholar]
  • 41. Rouleau GA, Merel P, Lutchman M et al (1993) Alteration in a new gene encoding a putative membrane organizing protein causes neurofibromatosis type 2. Nature 363:515–521. [DOI] [PubMed] [Google Scholar]
  • 42. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994) Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Gen 3:885–891. [DOI] [PubMed] [Google Scholar]
  • 43. Scherer SS, Xu T, Crino P, Arroyo EJ, Gutmann DH (2001) Ezrin, radixin, and moesin are components of Schwann cell microvilli. J Neurosci Res 65:150–164. [DOI] [PubMed] [Google Scholar]
  • 44. Schmucker B, Ballhausen WG, Kressel M (1997) Sub‐cellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin. European J Cell Biol 72:46–53. [PubMed] [Google Scholar]
  • 45. Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NG, Tamanoi F, Pulst SM (1998) Neurofibromatosis 2 tumour suppressor schwannomin interacts with betallspectrin. Nature Genet 18:354–359. [DOI] [PubMed] [Google Scholar]
  • 46. Shaw RJ, Paez JG, Curto M, Yaktine A, Pruitt WM, Saotome I, O'Bryan JP, Gupta V, Ratner N, Der CJ, Jacks T, McClatchey AI (2001) The Nf2 tumor suppressor, merlin, functions in Rac‐dependent signaling. Dev Cell 1:63–72. [DOI] [PubMed] [Google Scholar]
  • 47. Stewart HJ, Turner D, Jessen KR, Mirsky R (1997) Expression and regulation of alpha1beta1 integrin in Schwann cells. J Neurobiol 33:914–928. [DOI] [PubMed] [Google Scholar]
  • 48. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1994) Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 125:1371–1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K (1993) A novel moesin‐, ezrin‐, radixin‐like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791–800. [DOI] [PubMed] [Google Scholar]
  • 50. Turunen O, Wahlstrom T, Vaheri A (1994) Ezrin has a COOH‐terminal actin‐binding site that is conserved in the ezrin protein family. J Cell Biol 126:1445–1453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2‐related tumors. Am J Hum Genet 51:478–485. [PMC free article] [PubMed] [Google Scholar]
  • 52. Xu HM, Gutmann DH (1998) Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res 51:403–415. [DOI] [PubMed] [Google Scholar]
  • 53. Zang KD (2001) Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93:207–220. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES